(Q42225289)

19 October 2017

title

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use. (English)

1 reference

19 October 2017

main subject

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gabriele Missale

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Giuseppe Cabibbo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Giuseppe Cabibbo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Rodolfo Sacco

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

Francesco Giuseppe Foschi

13 June 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

Gianluca Svegliati-Baroni

13 June 2020

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Giorgio Sammito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Fabio Farinati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Francesca Ciccarese

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Anna Pecorelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gian Lodovico Rapaccini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Mariella Di Marco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Eugenio Caturelli

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Marco Zoli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Franco Borzio

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Martina Felder

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Antonio Gasbarrini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Filomena Morisco

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Roberto Virdone

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Franco Trevisani

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Italian Liver Cancer (ITA.LI.CA) Group

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

10 April 2014

1 reference

19 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

2150-2157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24723129%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Recent advances in the natural history of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Epidemiology of viral hepatitis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Hepatocellualar carcinoma serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Alphafetoprotein: an obituary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Effectiveness of α-fetoprotein for hepatocellular carcinoma surveillance: the return of the living-dead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

α-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Histopathology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

The changing scenario of hepatocellular carcinoma over the last two decades in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

7 January 2021

Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

7 January 2021

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

7 January 2021

Serum α-fetoprotein in fulminant hepatitis and hepatic regeneration following partial hepatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

7 January 2021

Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

7 January 2021

Hepatocellular carcinoma in patients with cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28706

7 January 2021